Search & Analyze

Torrent Pharmaceuticals Ltd.

HealthcarePharmaceuticals & Drugs

www.torrentpharma.com BSE: 500420NSE: TORNTPHARM

₹4,913.00BSE1.10%

07 Sep, 4:01 PM

₹4,913.00

₹1.87L Cr

85.68

20.82

26.76%

₹4,917.15

₹4,830.00

₹5,249.95

₹3,480.00

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,899.80	37.69	4,55,825.66	0.84	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,305.00	84.45	2,47,018.51	0.32	902.00	65.50%	3,080.00	27.80%	21.51
Torrent Pharmaceuticals Ltd. TORNTPHARM	4,913.00	85.68	1,86,874.73	0.77	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,155.00	25.53	1,15,211.69	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,395.95	33.46	1,12,773.00	0.93	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,868.25	92.32	1,00,943.83	0.11	362.07	123.94%	2,026.31	29.10%	18.20
LUPIN LTD. LUPIN	2,105.00	17.41	96,254.46	0.86	1,416.98	16.01%	8,276.89	32.04%	28.86
MANKIND MANKIND	2,322.05	46.95	95,911.14	0.04	574.09	29.12%	4,030.59	12.89%	13.24

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	2,745.00	2,859.00	2,889.00	2,809.00	2,959.00	3,178.00	3,302.00	3,303.00	4,197.00	4,921.00
Expenses	1,862.00	1,955.00	1,950.00	1,895.00	1,995.00	2,146.00	2,219.00	2,215.00	2,841.00	3,257.00
	883.00	904.00	939.00	914.00	964.00	1,032.00	1,083.00	1,088.00	1,356.00	1,664.00
	32.17%	31.62%	32.50%	32.54%	32.58%	32.47%	32.80%	32.94%	32.31%	33.81%
	31.00	24.00	-16.00	33.00	-42.00	-37.00	-40.00	-23.00	-83.00	-33.00
Interest	80.00	75.00	64.00	57.00	56.00	56.00	48.00	45.00	236.00	305.00
	203.00	197.00	198.00	199.00	201.00	201.00	204.00	206.00	508.00	593.00
	631.00	656.00	661.00	691.00	665.00	738.00	791.00	814.00	529.00	733.00
	28.84%	30.34%	31.47%	27.21%	25.11%	25.75%	25.28%	21.99%	31.19%	22.78%
	449.00	457.00	453.00	503.00	498.00	548.00	591.00	635.00	389.00	566.00
	13.27	13.50	13.38	14.86	14.71	16.19	17.46	18.76	11.49	16.72

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	15,211.13	16,320.65	16,705.39	16,853.82	19,680.70
	8,508.04	9,620.15	10,727.84	11,516.09	13,979.73
EXPENDITURE :
Increase/Decrease in Stock	73.86	166.19	-155.01	-274.92	11.40
Raw Material Consumed	2,156.89	2,347.01	2,613.96	2,830.55	3,112.55
Power & Fuel Cost	144.19	155.28	145.20	137.34	160.83
Employee Cost	1,526.45	1,677.69	1,984.40	2,203.37	2,670.85
Other Manufacturing Expenses	591.13	570.79	570.58	594.29	743.67
General and Administration Expenses	637.65	775.30	980.72	960.60	1,154.44
Selling and Distribution Expenses	884.91	1,026.99	1,129.68	1,260.67	1,490.90
Miscellaneous Expenses	61.69	76.93	94.72	99.84	261.92
	6,076.77	6,796.18	7,364.25	7,811.74	9,606.56
Operating Profit (Excl OI)	2,431.27	2,823.97	3,363.59	3,704.35	4,373.17
	196.56	63.22	61.97	39.91	91.71
	2,627.83	2,887.19	3,425.56	3,744.26	4,464.88
Interest	255.06	333.44	353.56	252.31	385.07
PBDT	2,372.77	2,553.75	3,072.00	3,491.95	4,079.81
	662.16	706.59	808.27	794.93	1,118.87
Profit Before Taxation & Exceptional Items	1,710.61	1,847.16	2,263.73	2,697.02	2,960.94
Exceptional Income / Expenses	-484.70		88.38	-24.21	-88.75
	1,225.91	1,847.16	2,352.11	2,672.81	2,872.19
Provision for Tax	448.73	601.93	695.73	761.56	734.01
	777.18	1,245.23	1,656.38	1,911.25	2,138.18
Extra items				0.00	0.00
Minority Interest					25.19
Consolidated Net Profit	777.18	1,245.23	1,656.38	1,911.25	2,163.37
Profit Balance B/F	2,806.47	2,916.68	3,303.19	3,942.40	4,746.55
Appropriations	3,583.65	4,161.91	4,959.57	5,853.65	6,909.92
Equity Dividend %	960.00%	440.00%	560.00%	640.00%	760.00%
	45.92	36.79	48.94	56.47	63.92
Adjusted EPS	22.96	36.79	48.94	56.47	63.92

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	84.62	169.23	169.23	169.23	169.23
Total Reserves	5,868.33	6,028.84	6,686.92	7,421.46	8,219.20
Reserve excluding Revaluation Reserve	5,868.33	6,028.84	6,686.92	7,421.46	8,219.20
Revaluation reserve	0.00
	5,952.95	6,198.07	6,856.15	7,590.69	8,388.43
Minority Interest					9,196.40
Secured Loans	2,123.22	2,496.22	1,603.78	1,191.75	11,651.17
Deferred Tax Assets / Liabilities	-300.09	-141.73	100.92	234.57	4,971.77
Other Long Term Liabilities	46.28	75.26	74.66	160.12	298.04
Long Term Provisions	368.74	393.06	444.69	501.27	764.55
Total Non-Current Liabilities	2,238.15	2,822.81	2,224.05	2,087.71	17,685.53
Trade Payables	1,674.44	1,678.80	2,089.32	1,820.02	2,357.61
Other Current Liabilities	1,365.10	1,578.41	1,130.15	1,143.50	2,451.48
Short Term Borrowings	923.04	1,765.07	1,637.71	1,249.97	2,914.57
Short Term Provisions	452.51	425.02	568.07	503.70	619.67
Total Current Liabilities	4,415.09	5,447.30	5,425.25	4,717.19	8,343.33
Total Liabilities	12,606.19	14,468.18	14,505.45	14,395.59	43,613.69
Gross Block	10,728.19	12,811.62	13,484.57	14,041.34	40,405.45
Less: Accumulated Depreciation	4,305.54	4,690.17	5,346.46	6,094.44	7,227.37
Net Block	6,422.65	8,121.45	8,138.11	7,946.90	33,178.08
Capital Work in Progress	544.34	688.24	280.80	367.26	457.49
Non Current Investments	42.33	42.70	31.80	43.57	82.62
Long Term Investment	42.33	42.70	31.80	43.57	82.62
Long Term Loans & Advances	166.55	181.04	349.34	294.29	281.33
Other Non Current Assets	50.19	28.41	14.21	10.12	24.35
Total Non-Current Assets	7,311.54	9,139.00	8,893.97	8,773.02	34,220.60
Currents Investments	183.98	156.09	141.04	112.21	865.74
Inventories	2,462.32	2,229.64	2,279.07	2,541.25	3,138.19
Sundry Debtors	1,632.48	1,943.82	1,844.30	1,866.45	3,030.86
Cash and Bank	403.41	571.46	839.04	579.46	1,165.20
Other Current Assets	331.62	246.89	327.99	323.62	404.27
Short Term Loans and Advances	151.18	165.82	180.04	199.58	787.63
Total Current Assets	5,164.99	5,313.72	5,611.48	5,622.57	9,391.89
Net Current Assets (Including Current Investments)	749.90	-133.58	186.23	905.38	1,048.56
Total Assets	12,606.19	14,468.18	14,505.45	14,395.59	43,613.69
Contingent Liabilities	128.74	150.83	157.44	156.12	379.25
Total Debt	4,018.10	5,297.30	3,937.42	3,026.09	14,798.24
	351.75	183.13	202.57	224.27	247.84
Adjusted Book Value	175.87	183.13	202.57	224.27	247.84

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	1,225.91	1,847.16	2,352.11	2,672.81	2,872.19
Adjustment	1,349.95	937.24	993.99	996.05	1,301.41
Changes In working Capital	-351.85	-18.20	418.08	-480.93	-341.97
Cash Flow after changes in Working Capital	2,224.01	2,766.20	3,764.18	3,187.93	3,831.63
Cash Flow from Operating Activities	1,802.99	2,368.13	3,266.08	2,585.11	3,022.71
Cash Flow from Investing Activities	-196.63	-2,415.31	-167.90	-540.05	-12,712.41
Cash Flow from Financing Activitie	-1,781.05	77.36	-2,779.64	-2,297.99	10,150.60
Net Cash Inflow / Outflow	-174.69	30.18	318.54	-252.93	460.90
Opening Cash & Cash Equivalents	572.56	398.40	508.53	835.14	573.48
Cash & Cash Equivalent on Amalgamation / Take over / Merger		58.83
Effect of Foreign Exchange Fluctuations	0.53	21.12	8.07	-8.73	82.82
Closing Cash & Cash Equivalent	398.40	508.53	835.14	573.48	1,117.20

Ratios

Valuation

85.68

20.82

39.15

12.09

57.34

235.97

Profitability

26.76

19.27

7.37

22.22

10.86

Leverage & Liquidity

1.76

1.13

8.46

Returns

0.77

0.68

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	71.25	71.25	68.31	68.31	68.31	68.31	68.31	68.31	68.31
	21.49	21.54	24.52	24.66	24.74	25.20	25.27	25.24	25.27
	7.26	7.21	7.17	7.03	6.94	6.49	6.42	6.45	6.42
	28.75	28.75	31.69	31.69	31.69	31.69	31.69	31.69	31.69
No. of Shareholders	74,765	79,848	85,035	86,005	81,856	78,226	76,214	83,811	85,776

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-07-16	Board Meeting	Quarterly Results
2026-05-22	Ex Dividend	Rs.9.0000 per share(180%)Final Dividend	2026-05-29	2026-05-29
2026-05-11	Board Meeting	Fund Raising & Final Dividend & Audited Results

Insider Trading

Date	Person	Category	Transaction Type	Shares
2026-06-03	Geena Malhotra	Market	Buy	200
2026-06-03	Geena Malhotra	Market	Buy	100
2026-06-01	Geena Malhotra	Market	Buy	100
2026-06-01	Geena Malhotra	Market	Buy	200

Sector Overview

HealthcarePharmaceuticals & Drugs

Torrent Pharmaceuticals Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

8 members across the board and senior leadership

Samir Mehta

Chairman

₹36.00 Cr

Mar '26

Ameera Shah

Non Executive Independent Director

₹60.00 L

Mar '25

Nayantara Bali

Non Executive Independent Director

₹76.00 L

Mar '26

Manish Choksi

Non Executive Independent Director

₹54.00 L

Mar '26

Nikhil Khattau

Non Executive Independent Director

₹76.00 L

Mar '26

Aman Mehta

Managing Director

₹18.82 Cr

Mar '26

Jinal Mehta

Non Independent & Non Executive Director

—

Chintan Trivedi

Company Secretary & Compliance Officer

—

TORNTPHARM Latest News

News

5 of 5 articles

COMPANY31 Jul 2026 · 10:08

Torrent Pharma reports marginal rise in Q1 consolidated net profit

Consolidated total income of the company has increased 56.29% at Rs 4,909 crore for Q1FY27

EQUITY16 Jul 2026 · 17:42

Torrent Pharmaceuticals informs about board meeting

EQUITY25 May 2026 · 14:05

Torrent Pharma jumps despite consolidated net profit falls 22% in Q4

The total consolidated income of the company has increased by 42.13% at Rs 4,180.00 crore for Q4FY26

COMPANY25 May 2026 · 12:21

Torrent Pharma’s consolidated net profit falls 22% in Q4

The total consolidated income of the company has increased by 42.13% at Rs 4,180.00 crore for Q4FY26

EQUITY22 May 2026 · 16:47

Torrent Pharma reports Profit after tax of Rs 4670.00 Mln, in the March 2026 quarter

TORNTPHARM

₹4,913.00

+1.1%